Scatterplot of observed barrier scores against knowledge scores (top) and confidence scores (bottom) with linear line of best fit. by Lisa Thiele (6468056)

Significant Wilcoxon test results of the Task 1 Nasa TLX data, differences between feedback ON and OFF. by Mucahit Gemici (21519313)

The spike-in of synthetic hsa-lest-7a-5p miRNA decreases the Ct Values of extracted small RNA samples. by Marc Van Der Hofstadt (1423027)

Linear Mixed-Effects Model analysis of bone mineral density changes in relation to urinary cadmium levels in a 3-Year Period. by Aroon La-up (14095691)

Subjects:

Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for garbanzo trypsinised with shades of green showing increase and red showing decrease with respect to soaked. by Indrani Bera (804948)

“…<p>Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for garbanzo trypsinised with shades of green showing increase and red showing decrease with respect to soaked.…”

Demographic characteristics of study participants. by Bao Vu Ngoc (14551955)

Subjects:

Proportion of first-time testers by key population group. by Bao Vu Ngoc (14551955)

Subjects:

Comparative cost analysis of HCVST and PL-HCVT models (in US$). by Bao Vu Ngoc (14551955)

Subjects:

Incremental costs per month for different HCV testing models. by Bao Vu Ngoc (14551955)

Subjects:

Comparative costs of HCVST and PL-HCVT models in sensitivity analysis (in US$). by Bao Vu Ngoc (14551955)

Subjects:

HCV positivity rate by key population group opting for HCVST and standard HCVT. by Bao Vu Ngoc (14551955)

Subjects:

Proportion of first-time HCV testers by testing model. by Bao Vu Ngoc (14551955)

Subjects:

Insulin-free survival in patients with and without FHD. by Clemens Plattner (21567706)

Subjects:

Event-free survival analysis of microvascular outcome. by Clemens Plattner (21567706)

Subjects:

Event-free survival analysis of macrovascular outcome. by Clemens Plattner (21567706)

Subjects:

Fundamental Characteristics of Participants by PAL. by Haiwei Li (282229)

Subjects:

Fundamental Characteristics of Participants with and without CVD. by Haiwei Li (282229)

Subjects:

Data. by Haiwei Li (282229)

Subjects:

Flow diagram of the participants screening procedures. by Haiwei Li (282229)

Subjects:

Restricted cubic spline plots showing the association between changes in PAL and risk of CVD. by Haiwei Li (282229)

Subjects: